Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

Hansoh Signs $456 Million Agreement for siRNA Products from OliX Pharma

AffyImmune Raises $30 Million for CAR-T Therapies from HK Investor

JW Therapeutics to Launch CD-19 CAR-T in China for Lymphoma

NeuExcell Raises $10 Million For Gene Therapies Aimed at Neurodegenerative Repair

Jacobio Invests $53 Million into Hebecell and its Stem Cell Based CAR-T Therapies

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China